Family Office Briefing on research byTranswestern·Sep 12, 2025
Houston Life Sciences Research Report - Summer-Fall 2025
Houston life sciences market shows strong venture capital growth in 2025 — family offices should consider co-GP opportunities with emerging operators.
Key Metrics
| Metric | Value |
|---|---|
| Houston CPRIT Funding | 65.1M |
| Houston Venture Capital Funding | 310.1M |
| Houston NIH Funding | 471.8M |
| Direct Vacancy | 14.1% |
| Total Availability | 15.9% |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Transwestern
Building a thesis around Houston? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.